168 related articles for article (PubMed ID: 26791129)
1. Unusual cause of general malaise: a young woman with ornithine transcarbamylase deficiency.
Singh S; Pal S; Dubrey SW
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791129
[TBL] [Abstract][Full Text] [Related]
2. Prenatal treatment of ornithine transcarbamylase deficiency.
Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
[TBL] [Abstract][Full Text] [Related]
3. Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency.
Koya Y; Shibata M; Senju M; Honma Y; Hiura M; Ishii M; Matsumoto S; Harada M
Intern Med; 2019 Apr; 58(7):937-942. PubMed ID: 30449781
[TBL] [Abstract][Full Text] [Related]
4. Hyperammonemia in a patient with late-onset ornithine carbamoyltransferase deficiency.
Choi DE; Lee KW; Shin YT; Na KR
J Korean Med Sci; 2012 May; 27(5):556-9. PubMed ID: 22563224
[TBL] [Abstract][Full Text] [Related]
5. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
Unsinn C; Das A; Valayannopoulos V; Thimm E; Beblo S; Burlina A; Konstantopoulou V; Mayorandan S; de Lonlay P; Rennecke J; Derbinski J; Hoffmann GF; Häberle J
Orphanet J Rare Dis; 2016 Aug; 11(1):116. PubMed ID: 27538463
[TBL] [Abstract][Full Text] [Related]
6. Urea cycle disorders: a life-threatening yet treatable cause of metabolic encephalopathy in adults.
Blair NF; Cremer PD; Tchan MC
Pract Neurol; 2015 Feb; 15(1):45-8. PubMed ID: 25125564
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients.
Burlina AB; Ogier H; Korall H; Trefz FK
Mol Genet Metab; 2001 Apr; 72(4):351-5. PubMed ID: 11286510
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome and intervention of urea cycle disorders in Japan.
Kido J; Nakamura K; Mitsubuchi H; Ohura T; Takayanagi M; Matsuo M; Yoshino M; Shigematsu Y; Yorifuji T; Kasahara M; Horikawa R; Endo F
J Inherit Metab Dis; 2012 Sep; 35(5):777-85. PubMed ID: 22167275
[TBL] [Abstract][Full Text] [Related]
9. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
Scaglia F; Carter S; O'Brien WE; Lee B
Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
[TBL] [Abstract][Full Text] [Related]
10. Ornithine transcarbamylase deficiency presenting as recurrent abdominal pain in childhood.
Mhanni AA; Prasad C; Rockman-Greenberg C
Pediatr Emerg Care; 2011 Sep; 27(9):850-3. PubMed ID: 21926883
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment of girls with ornithine transcarbamylase deficiency.
Maestri NE; Brusilow SW; Clissold DB; Bassett SS
N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603
[TBL] [Abstract][Full Text] [Related]
12. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
Enns GM; Berry SA; Berry GT; Rhead WJ; Brusilow SW; Hamosh A
N Engl J Med; 2007 May; 356(22):2282-92. PubMed ID: 17538087
[TBL] [Abstract][Full Text] [Related]
13. Successful early management of a female patient with a metabolic stroke due to ornithine transcarbamylase deficiency.
Tummolo A; Favia V; Bellantuono R; Bellino V; Ranieri A; Morrone A; De Palo T; Papadia F
Pediatr Emerg Care; 2013 May; 29(5):656-8. PubMed ID: 23640148
[TBL] [Abstract][Full Text] [Related]
14. [Hyperammonemia type II as an example of urea cycle disorder].
Hawrot-Kawecka AM; Kawecki GP; Duława J
Wiad Lek; 2006; 59(7-8):512-5. PubMed ID: 17209350
[TBL] [Abstract][Full Text] [Related]
15. The urea cycle disorders.
Helman G; Pacheco-Colón I; Gropman AL
Semin Neurol; 2014 Jul; 34(3):341-9. PubMed ID: 25192511
[TBL] [Abstract][Full Text] [Related]
16. Adult onset ornithine transcarbamylase deficiency: an unusual cause of semantic disorders.
Rimbaux S; Hommet C; Perrier D; Cottier JP; Legras A; Labarthe F; Lemarcis L; Autret A; Maillot F
J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1073-5. PubMed ID: 15201380
[TBL] [Abstract][Full Text] [Related]
17. The role of orthotopic liver transplantation in the treatment of ornithine transcarbamylase deficiency.
Busuttil AA; Goss JA; Seu P; Dulkanchainun TS; Yanni GS; McDiarmid SV; Busuttil RW
Liver Transpl Surg; 1998 Sep; 4(5):350-4. PubMed ID: 9724471
[TBL] [Abstract][Full Text] [Related]
18. Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency.
Nagasaka H; Yorifuji T; Murayama K; Kubota M; Kurokawa K; Murakami T; Kanazawa M; Takatani T; Ogawa A; Ogawa E; Yamamoto S; Adachi M; Kobayashi K; Takayanagi M
Eur J Pediatr; 2006 Sep; 165(9):618-24. PubMed ID: 16703326
[TBL] [Abstract][Full Text] [Related]
19. Treatment of urea cycle disorders.
Thoene JG
J Pediatr; 1999 Mar; 134(3):255-6. PubMed ID: 10064655
[No Abstract] [Full Text] [Related]
20. Late diagnosis of ornithine transcarbamylase defect in three related female patients: polymorphic presentations.
Legras A; Labarthe F; Maillot F; Garrigue MA; Kouatchet A; Ogier de Baulny H
Crit Care Med; 2002 Jan; 30(1):241-4. PubMed ID: 11902270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
